Joslyn S. Kirby

North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populations

Outcome Measures for the Evaluation of Treatment Response in Hidradenitis Suppurativa for Clinical Practice

Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa

Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States

Psychosocial impact of hidradenitis suppurativa: a practical guide for clinicians

Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report

What causes hidradenitis suppurativa ?—15 years after

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (<scp>SHSA</scp>) 2017

Trends in utilization of topical medications for treatment of rosacea in the United States (2005-2014): A cohort analysis